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Locked nucleic acidsMicroRNAs (miRNAs) are small regulatory RNAs, which mediate selective repression of gene expres-
sion. miRNAs play important roles in many natural and pathological processes. Numerous tools
were developed for their detection and functional analysis. There are many excellent articles cover-
ing different areas of miRNA biology in detail. At the same time, I think there are many colleagues
who face a miRNA-related research problem and would appreciate having an introductory general
overview of tools for miRNA analysis, which would help them in considering available options.
Accordingly, this review provides an elementary roadmap to navigate among available tools for
miRNA analysis. The most common problems and errors observed in miRNA research are also
discussed.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The last decade witnessed explosive growth of the microRNA
(miRNA) ﬁeld. There are countless original and review articles
describing all possible aspects of miRNA biology in very great
detail. At the same time, I feel it might be difﬁcult for a
non-expert to get quickly oriented in the ﬁeld and ﬁnd a speciﬁc
solution to his/her miRNA-related problem. I had two main moti-
vations to write this review, which should be seen as an elemen-
tary small scale map of the world of miRNA analysis. First, I
wanted to provide an introductory material allowing for under-
standing the basics of miRNA analysis and starting exploring fur-
ther details in the referenced literature. Second, I wanted to
highlight the problem of stoichiometry between miRNAs and their
targets, which needs to be taken into account when studying phys-
iological roles of miRNAs and performing their functional analysis.
The review has two parts, which follow a basic introduction into
miRNA biogenesis and function. The ﬁrst part deals with analyzing
miRNA presence, abundance, and activity. The second part is
focused on functional analysis of miRNAs, where I discuss tools
for manipulating miRNA levels and options for identiﬁcation and
validation of miRNA targets.2. Essentials of miRNA biogenesis and function
miRNAs are genome-encoded short RNAs that regulate gene
expression by mediating translational repression and/or degrada-
tion of cognate mRNAs. miRNAs play important roles in many pro-
cesses and are the most common type of small RNAs found in
mammalian cells. Biogenesis of canonical and non-canonical
miRNAs has been summarized in detail elsewhere [1–4]. Here, I
will only brieﬂy summarize essential information concerning
canonical miRNA biogenesis in animals (Fig. 1A).
Canonical miRNAs are transcribed by RNA polymerase II as long
primary transcripts (pri-miRNAs), which are cleaved by RNase III
Drosha, a component of the nuclear ‘‘microprocessor’’ complex,
to release short hairpin intermediates (pre-miRNAs). Pre-miRNAs
are transported to the cytoplasm where they are further
processed by RNase III Dicer (Fig. 1B) into 22 nucleotide
(nt)-long double-stranded RNA molecules. Some animals (e.g.
Caenorhabditis and vertebrates) have one Dicer producing different
types of small RNAs from different substrates while others
(exempliﬁed by Drosophila) have a speciﬁc Dicer isoform dedicated
to the miRNA pathway.
One strand of the duplex produced by Dicer is selected and
loaded onto an Argonaute protein (Fig. 1C), the miRNA-carrying
component of the effector ribonucleoprotein complex, which rec-
ognizes and represses target mRNAs. The AGO-containing effector
complex has been given different names, here I will refer to it as
miRNA-Induced Silencing Complex (miRISC). In mammals, four
AGO proteins, AGO1–4, associate with miRNAs and are implicated
Fig. 1. miRNA pathway in mammals. (A) A schematic overview of miRNA biogenesis and action. (B) Domain organization of Dicer RNase III, the key player in biogenesis of
miRNAs and siRNAs (reviewed in [1,90]). Mammalian Dicer is 215kDa protein containing several conserved domains, including N-terminal DEAD-like and helicase
superfamily C domains, the piwi/argonaute/zwille (PAZ) domain, two RNase III domains, and the C-terminal double-stranded RNA binding domain (dsRBD). The PAZ domain
binds a 30 protruding overhang in dsRNAs or miRNA precursors. Two RNase III domains (depicted as red Pac-Men) form a single processing center producing a short dsRNA
with a 2 nt 30 overhang, where each domain cleaves one strand of the duplex. Thus, Dicer acts as a molecular ruler, measuring the substrate length from the PAZ domain to
RNase III domains. The scheme of Dicer organization is based on previous structural studies [91,92]. (C) Domain organization of an Argonaute protein based on previous
structural studies of AGO2 [5,8]. AGO proteins have four domains (N-terminal (N), PIWI, middle (MID), and PAZ). The small RNA (miRNA or siRNA (blue)) binds with its 30 end
in the PAZ domain and the 50 binds a binding pocket in the MID domain. The mRNA (black) enters between the N-terminal and PAZ domains and exits between the PAZ and
middle domain. A perfect duplex of a small RNA and mRNA ﬁts into a groove in AGO2 such that the active site in the PIWI domain (depicted as a red Pac-Man) cleaves the
mRNA opposite the middle of the siRNA guide. Imperfect base pairing or other AGO isoforms mediate translation repression, which requires additional co-factors, including
GW182.
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speciﬁc endonucleolytic cleavage of a target mRNA in the middle
of the sequence base paired with a short RNA [5,6,8]. Whether
AGO2-loaded short RNA will mediate endonucleolytic cleavage or
induce translational repression depends on the extent of base pair-
ing with its mRNA target. The AGO2-mediated endonucleolytic
cleavage requires formation of a perfect or nearly perfect
miRNA:mRNA duplex, exempliﬁed by mammalian mir-196 and
HoxB8 mRNA [9]. However, complementarity between animal
miRNAs and their cognate mRNAs is typically imperfect while
the endonucleolytic cleavage has been traditionally attributed to
RNA interference (RNAi) pathway. Functional base pairing of
miRNAs with their mRNA targets appears to involve little beyond
the ‘‘seed’’ region comprising nucleotides 2–8 of the miRNA
[10,11].
Imperfect miRNA:mRNA base pairing results in translational
repression [12,13] followed by substantial mRNA degradation
[14,15], which actually facilitates identiﬁcation of primary
miRNA targets through transcriptome proﬁling. The molecular
mechanism of mRNA degradation induced by imperfect base pair-
ing differs from the above-mentioned AGO2-mediated endonucle-
olytic cleavage [16] and involves deadenylation and decapping
activities [17–20]. Recent data suggest that RNA degradation is
actually the dominant component of cognate gene repression
[21]. Repressed mRNAs, miRNAs, and AGO proteins localize to
cytoplasmic foci known as P-bodies [22,23], which contain mRNA
degrading enzymes such as the decapping complex, deadenylases,
and the exonuclease XRN1 (reviewed in [24]).
Thousands of miRNAs have been annotated in different species.
The central miRNA database miRBase (http://www.mirbase.org)
[25] contains 28645 entries, including 2588 human, 1915 murine,
466 Drosophila melanogaster and 434 Caenorhabditis elegansmaturemiRNAs (release 21). miRNAs were implicated in countless cellular
and developmental processes and changes in their expression are
observed in various diseases. At the same time, the function of
most miRNAs and suppression of their cognate genes are poorly
understood. One of the bioinformatic estimates suggests that over-
all miRNAs might directly target over 60% of mammalian genes
[26]. Functional analyses in different mammalian cell types,
including effects of ectopic expression of miRNAs [15], inhibition
of individual miRNAs by antisense molecules [27] or miRNA path-
way knock-down [16] or knock-out [28,29] suggest that in one cell
type (i) a signiﬁcant portion of the transcriptome (thousands of
genes) is affected (directly and indirectly) by miRNA activity and
that (ii) a single miRNA might directly suppress expression of up
to several hundred genes.
The set of miRNAs in each cell type forms a combinatorial
post-transcriptional regulation system shaping gene expression
in an analogy to a trimming stencil. miRNAs have widespread
impact on expression and evolution of protein-coding genes
(reviewed in [30]). Evolution of miRNA regulations is very fast.
For example, there are only a few miRNAs conserved between
Drosophila and mammals. Animal miRNAs seem to emerge from
random formation of Drosha/Dicer substrates. Newly evolving
miRNAs likely form a considerable portion of annotated miRNAs,
especially in species where miRNAs were intensely studied by next
generation sequencing (NGS), which can identify low-abundance
miRNAs. The newly emerging miRNAs either acquire signiﬁcant
repressive functions and become retained during evolution or they
become lost. Furthermore, target repertoire of individual miRNAs
can evolve fast since a single point mutation can weaken an exist-
ing regulation or create a new one. This idea is consistent with the
data showing that mammalian mRNAs are under selective pressure
to maintain and/or avoid speciﬁc 7-nucleotide seeding regions
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where a single mutation creating a novel miRNA target site in myo-
statin causes the renowned exceptional meatiness of this breed
[32]. The number of mRNAs that have functionally important inter-
action with miRNAs in a studied model system is presumably small
and certainly difﬁcult to discern among the all possible interac-
tions. Thus, every search for functionally important interactions
between miRNAs and their targets has to face the fact that
miRNAs represent a dynamically evolving system with countless
random interactions, which are not biologically relevant.
3. miRNA proﬁling – miRNA detection & quantiﬁcation
Several methods can be used for detecting individual miRNAs.
The oldest method for miRNA detection is Northern blotting [33],
which was also adopted as the golden standard for annotating
novel miRNAs [34]. There are several online protocols for miRNA
Northern blotting using RNA or DNA radiolabeled oligonucleotides
[35] or an adaptation using so-called locked nucleic acids (LNA)
probes [36], which offer higher hybridization afﬁnity [37].
While Northern blotting is relatively labor-intensive, it is an
invaluable tool for obtaining insights into regulation of miRNA
biogenesis and degradation. One of the main Northern blot
advantages is that it reveals in a single experiment miRNA and
pre-miRNA amounts and ratios, miRNA length variability, and
covalent modiﬁcations.
The more common approach for monitoring individual miRNA
levels is nowadays real-time reverse-transcription PCR (qPCR),
for which there is a number of protocols and commercial assays
(e.g. miRCURY LNA qPCR from Exiqon or TaqMan assays from
ABI). qPCR has a high sensitivity and can be performed on a mini-
mal amount of material – for example, a qPCR protocol allowing for
a quantitative analysis of 220 miRNAs from a single cell has been
described [38]. cDNA preampliﬁcation combined with a qPCR array
system allows for a rapid analysis of a large number of samples.
Sufﬁcient number of replicates is also important for quantitative
single-cell qPCR analysis, one has to take into the account stochas-
ticity of single-cell expression and analyze enough cells [39].
Available 48  48 and 96  96 qPCR array formats (e.g. Fluidigm)
allow for analysis of 48 or 96 miRNAs in 48 or 96 samples, respec-
tively. Since analyzing 48 or 96 miRNAs is sufﬁcient for most appli-
cations, PCR arrays offer the best option in terms of the total price
per analyzed sample. At the same time, qPCR is more prone to arti-
facts resulting in false positives and quantiﬁcation errors than a
Northern blot, which directly detects miRNAs in a non-ampliﬁed
RNA sample.
The third common individual miRNA detection approach is
in situ hybridization, which is a powerful tool for spatiotemporal
resolution of miRNA expression, especially in cases where one
has to rely on histology. As miRNAs are short, it has been challeng-
ing to optimize detection conditions when adapting traditional
in situ RNA hybridization protocols. A major breakthrough was
made by introduction oligonucleotides containing LNA nucleo-
tides, which improve hybridization properties since they have
higher melting temperature than DNA or RNA oligonucleotides
[37]. LNA-containing oligonucleotides are nowadays the standard
approach for miRNA in situ detection in tissues or during develop-
ment [40,41].
In addition to the aforementioned ‘‘traditional methods’’ of
miRNA detection, an interesting progress can be observed in elec-
trochemical sensing approaches (reviewed in [42]). These methods
offer high sensitivity and great potential for developing instru-
ments for routine assessment of speciﬁc miRNA content in biolog-
ical samples. As such, these approaches will presumably have more
use in diagnostic/clinical set up rather than in common molecular
biology labs.3.1. miRNA proﬁling by microarrays
Microarrays are one of the twomost common strategies for pro-
ﬁling a miRNA population in a sample (the second one is NGS, dis-
cussed further below). Microarray proﬁling based on detecting
complementarity between nucleic acids in the sample and nucleic
acids arranged in an array has been developed for proﬁling gene
expression since mid 90’s [43]. Conceivably, microarrays were
rapidly adapted for miRNA proﬁling [44–47] and a number of
microarray platforms has been developed, some of which are avail-
able commercially. Detailed discussion of different platforms and
experimental designs is beyond the scope of this review and can
be found elsewhere [48,49]. Here, I would only brieﬂy highlight
main advantages and disadvantages of miRNA microarrays for
gene-by-gene or genome-wide proﬁling and underscore the
importance of the right experimental design including appropriate
controls.
Detection on microarrays is restricted for probes, which are
arrayed on them. Thus, microarrays are generally suitable for com-
paring expression of annotated miRNAs but cannot reveal novel
miRNAs. A general problem of miRNA hybridization is that optimal
hybridization temperature varies for different miRNAs, which
makes it difﬁcult to ﬁnd hybridization conditions optimal for all
microarray probes. A possible solution to this problem was pro-
vided by LNA, which offer higher melting temperature than DNA
or RNA duplexes [37]. Thus, oligonucleotide probes on an array
can be designed to contain various amounts of LNA nucleotides
to adjust optimal hybridization temperatures for all miRNAs.
However, when using microarrays, one should always keep in
mind the risk of cross-hybridization among closely related
miRNAs and that microarrays are less informative than NGS.
miRNA proﬁling by microarrays typically requires 100 ng–1 lg
of total RNA, which is similar to NGS. In contrast to NGS, microar-
ray proﬁling traditionally offered a faster and cheaper solution
with a lower resolution and a lower dynamic range [50].
However, with constantly diminishing costs of sequencing per
nucleotide combined with multiplexing options, NGS might easily
become ﬁnancially superior option. Therefore, I recommend calcu-
lating all presently available options before one commits to one
high-throughput system. For the choice, it is also important, what
one expects from the proﬁling and how much information is will-
ing to process and analyze. NGS is superior to microarrays and
qPCR because it reveals the entire miRNA population, including
rare and unannotated miRNAs, heterogeneity of miRNA species
produced from a single pre-miRNA, and allows to precisely distin-
guish, which miRNA family members are expressed.
This might be important especially in diagnostics and for
screening a large number of samples for biomarkers.
3.2. miRNA proﬁling by next generation sequencing (NGS)
NGS revolutionized miRNA proﬁling. This is unsurprising
because short miRNAs with deﬁned (i.e. annotated) sequences
are an optimal material for NGS. There are several different NGS
platforms available (for a comparison, see the reference [51]).
Platform selection is the matter of availability and cost; these are
constantly changing variables as new instruments and sequencing
services are available while the cost per base is constantly declin-
ing. Because of the constantly changing landscape of NGS one
needs to survey presently available options when considering
NGS analysis. The cost of commercial NGS services typically breaks
down into library preparation, sequencing, and data analysis and
often needs to be directly inquired/negotiated.
In my lab, we have had a good experience with both, SOLiD (by
Sequomics in Hungary) and Illumina (EMBL, Germany) sequencing
platforms over the past few years. However, as bioinformatic
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Illumina sequencing now. For detailed analysis of small RNAs, we
used multiplexing of 50-nt single-end (50SE) sequencing on
HiSeq 2000, which yielded depths in tens of millions reads at the
cost of 400 Euros/sample for 6–8 RNA samples. This depth was
sufﬁcient to detect rare small RNAs (including endo-siRNA)
[52,53]. A lower NGS depth (up to ten million reads) would be suf-
ﬁcient for routine miRNA proﬁling (especially if the studied cell
population is homogeneous). Furthermore, development of NGS
platforms and multiplexing options offers highly reduced costs
per sample at excellent sequencing depths.
Before miRNA proﬁling by NGS, I highly recommend to consult
normalization options with the NGS provider and include spiking
controls whenever possible because having an external normaliza-
tion standard is invaluable. Next, it is important to be prepared for
data management and analysis. NGS providers typically offer data
analysis (usually for extra charge), which should satisfy common
needs for simple differential expression analysis. A recommended
solution, however, is to ﬁnd local bioinformatics support or to learn
how to analyze the data. The last option is more plausible than it
sounds thanks to web-based platforms for miRNA expression anal-
ysis, such as oasis [54], MAGI [55] or older and more complex
Galaxy [56,57]. Importantly, NGS is a great tool, however, it is also
prone to artifacts, which might distort miRNA representation in the
original sample [58]. Therefore, one should not rely solely on NGS
data when inferring a speciﬁc miRNA abundance in a sample but,
whenever suitable, complement the analysis with Northern blot
or qPCR analyses.
4. Monitoring biological activity of miRNAs with reporters
A common way of monitoring miRNA activity employs repor-
ters carrying miRNA binding sites in the 30UTR. One option is to
use a natural 30UTR of a known miRNA target. For example,
lin-41 30UTR targeted by let-7 miRNA has been combined with
coding sequences of EGFP [59,60], lacZ [61], or luciferase [62]. A
neat system for monitoring let-7 activity in C. elegans was devel-
oped by co-expressing non-targeted mCherry and let-7-targeted
GFP in the distinctly shaped pharynx [63]. In the absence of
let-7, both red and green ﬂuorescence is observed. When let-7 is
expressed, the GFP reporter is repressed and only red ﬂuorescence
is observed. This sensor system can be used to study regulation of
let-7 activity and allows for high-throughput screening using
ﬂuorescence-activated worm sorting.
The most common reporter systems in cultured mammalian
cells are those using dual luciferase reporters. Typically, one luci-
ferase reporter (e.g. ﬁreﬂy) serves as a normalization control, while
the other one (e.g. Renilla) is targeted by a selected miRNA through
miRNA binding sites in the 30UTR (Fig. 2A and B). Reporters can
also carry artiﬁcial miRNA binding sites, either with perfect or par-
tial complementarity to a miRNA [12,16,23]. The number and the
type of miRNA binding sites allow to modulate reporter sensitiv-
ity/degree of downregulation by endogenous miRNAs. The reporter
system ideally includes a negative control made of a mutated tar-
geted reporter where point mutations are introduced into miRNA
binding sites to disrupt miRNA-mediated repression. The mutant
control is better than using a completely unrelated 30UTR (e.g.
commercial luciferase reporter with SV40 30UTR) because the dif-
ference between targeted and mutated reporter 30UTRs is small
and the effect of miRNA-mediated repression can be attributed to
speciﬁc 30UTR nucleotides. Using a negative control carrying an
unrelated 30UTR in the control reporter increases the risk that the
negative control reporter will generate artifacts because its 30UTR
would inﬂuence translation and/or mRNA half-life distinctly from
the targeted 30UTR but in a miRNA-independent fashion.Finally, adding MS2 binding sites to the luciferase reporter
allows for visualization of localization of targeted RNA to
P-bodies by co-expressing MS2-YFP [62] (Fig. 2C). In this case, 12
MS2 binding sites were inserted into a miRNA-sensitive luciferase
reporter and the visualization is achieved by co-expression of
MS2-YFP fusion protein carrying a nuclear localization signal, so
the unbound MS-YFP is sequestered in the nucleus [62,64]. This
type of reporter might be very helpful for target validation
because it reveals two distinct miRNA effects at the same
time – translational repression (monitored by luciferase assay)
and miRNA-dependent localization into P-bodies (revealed by
microscopy).
5. Approaches to manipulate miRNA levels
5.1. miRNA overexpression
To increase miRNA levels in cells, common RNAi tools (reviewed
for example in [65,66]) can be easily adapted. In mammals, RNAi
and miRNA pathway essentially converge upon cleavage by
Dicer. Therefore, short interfering RNA (siRNA) and short hairpin
RNA (shRNA) expression can be directly employed for miRNA
upregulation. A transient increase can be achieved by transfecting
siRNA carrying the miRNA sequence (so-called miRNA mimic) or
using shRNA-expressing plasmid where one has a choice between
polymerase III-driven shRNAs, which are Drosha-independent, or
polymerase II-driven shRNAs, which are processed like endoge-
nous miRNAs [67]. Such miRNA expression systems allow for
stable or inducible expression in cultured cells or entire organisms.
Importantly, miRNA overexpression data must be carefully inter-
preted since miRNA overexpression can easily generate false posi-
tives due to (i) non-physiological stoichiometry of the
overexpressed miRNA resulting in artiﬁcial repression and (ii)
miRISC saturation by the overexpressed miRNA, which results in
relieved repression of natural targets of other miRNAs.
5.2. Global suppression of the miRNA pathway
Several strategies can be used for modulating the miRNA
pathway. It can be inhibited by knocking-down or knocking-out
individual miRNA pathway components, such as Dicer or Drosha
(e.g. [16,29,68]), or by plant virus-encoded repressors [69].
However, these strategies have certain limits. For example, the
knock-down/knock-out strategy is constrained by the targeted
protein-product half-life, thus the inhibition cannot be rapidly
induced. This might be a problem, for example, when addressing
the role of miRNAs in rapidly changing model systems. The
knock-out approach used to be restricted to embryonic stem cells
(ESCs) and cells derived from ESCs or from mutant animals (e.g.
mouse embryonic ﬁbroblasts). However, the recent progress in
guided nucleases [70,71] makes it feasible to produce knock-outs
also in commonly used cell lines. In our experiments with miRNA
reporters in HeLa, HEK293 and 3T3 cell lines, knock-down of
Ago2 or Dicer signiﬁcantly relieved the miRNA-mediated repres-
sion (2–3-fold) while expression of plant virus repressors P19
and P21 had minimal effects.
A possible future alternative to the above-mentioned
approaches could be small compound modulators. Small com-
pound modulators of Dicer or miRISC identiﬁed through chemical
biology would be a great tool for studying RNAi and miRNA path-
ways in vivo and in vitro. In fact, several putative small compound
inhibitors and stimulators of the miRNA pathway were reported
(reviewed in [72]) but their speciﬁcity for the miRNA pathway
was not demonstrated and none of them has been developed into
an experimentally useful tool, so far.
Fig. 2. Tools for functional analysis of miRNAs. (A) miRNA-sensitive reporters based on fusing 30UTR of a targeted mRNA with a reporter. The targeted endogenous mRNA is
labeled with orange color, the targeting miRNA is shown in red. The miRNA binding site is depicted as a black region in the 30UTR. Below the endogenous cognate mRNA are
schemes of two reporter mRNAs, where the upper one is repressed by the miRNA and the lower one is resistant to miRNA repression. A gray X represents a mutation
disrupting base pairing between the miRNA and the reporter. (B) Artiﬁcial reporters carrying bulged and perfect complementarity types of miRNA binding sites. miRNA
binding sites are depicted as black regions in the 30UTR, miRNAs are shown in red. The graph below is an example of reporter utilization. In this particular example, reporter
plasmids were transfected into 3T3 cells per well in a 24-well plate and luciferase activities were assayed 48 h post-transfection. SV40 promoter-driven reporters contained
either one perfect or four bulged or four mutated miR-30 sites [64]. The y axis show relative expression formalized to the non-targeted ﬁreﬂy luciferase and set to one for the
mutated reporter. Error bar = S.E.M. (C) miRNA-repressed reporters, whose cytoplasmic localization can be visualized in cells through MS2 binding sites (depicted as three
stem loops downstream of miRNA binding sites), which are recognized by a ﬂuorescent protein (here YFP) fused with MS2 binding domain [62]. (D) Examples of
oligonucleotide inhibitors of miRNA function described in the text. Different chemistries are indicated in the lower panel. Ch indicates cholesterol moiety at the 30 end of an
antagomir. (E) Selective miRNA inhibitor. The scheme depicts the principle of action of miRNA inhibitors – an oligonucleotide binds a miRNA and prevents repression of a
cognate mRNA. The graph depicts effects of a Let-7 family short LNA inhibitor (Exiqon) on expression of luciferase reporters. HeLa cells were transfected with Let-7 reporters
[16] (1 ng/well/24-wellplate) and 1 lM of LNA inhibitor. Cells were assayed 24 h post-transfection and data were normalized as in Fig. 2B. (F) Target protector. The scheme
depicts the principle of action of target protectors – a morpholino oligonucleotide (in green) binds a miRNA binding site (black) and thus blocks miRNA-mediated repression
of the cognate mRNA.
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A traditional approach for selective miRNA inhibition would be
a knock-out. Several years ago, including knock-out strategy
among the experimental tools for selective miRNA inhibition
would be a formal acknowledgment of the approach rather than
a useful advice. However, guided nucleases mentioned above
[70,71] allow for relatively simple generation of knock-out models,
including common cultured cell lines. Therefore, genetic manipula-
tion of a miRNA is certainly worth of considering nowadays.
Other strategies to selectively block miRNAs include sequester-
ing miRNAs with so-called miRNA sponges or employing various
complementary oligonucleotides (Fig. 2D), which bind miRNAs
and render them non-functional or even destabilize them.5.3.1. Oligonucleotide inhibitors – antagomirs, target protectors and
others
miRNAs can be selectively and irreversibly inhibited by stoi-
chiometric amounts of 20-O-methyl oligoribonucleotides (Fig. 2D)
in vitro and in vivo [73,74]. Initial experiments in cultured
cells used 24-nt 20-O-methyl oligoribonucleotides that contained
a 30C7 aminolinker (to enable postsynthetic conjugation of
non-nucleotidic residues such as biotin) [73] or 31-nt
20-O-methyl oligoribonucleotides [74]. The term antagomir, which
is often used as a common name for oligonucleotide miRNA inhibi-
tors, was introduced for 21-nt cholesterol-conjugated 20-O-methyl
oligoribonucleotides carrying phosphorothioate linkages between
several nucleotides at 50 and 30 ends (Fig. 2D). Antagomirs are suit-
able for in vivo applications in animal models as well [27]. Similar
P. Svoboda / FEBS Letters 589 (2015) 1694–1701 1699effects can be achieved by miRCURY LNA miRNA inhibitors, which
use different chemistry and which can be obtained as mixmers of
LNA and DNA oligonucleotides with phosphodiester or phospho-
rothioate bonds. As LNAs offer highly stable base pairing, short
oligonucleotides (8-mers) can be used to inhibit entire miRNA fam-
ilies through targeting the common seed regions (Fig. 2D and E).
Target protectors [75] represent a different class of oligonu-
cleotide inhibitors as they selectively disrupt inhibition of a single
cognate mRNA (Fig. 2D and F). Target protectors represent an alter-
native use of morpholino oligonucleotides, which have been devel-
oped to suppress mRNA translation by binding to the translation
start site. As morpholinos are stable and do not destabilize
mRNAs, they can be effectively used to mask miRNA binding sites
in the 30UTR without disturbing normal gene function [75]. Target
protectors are great tools for target validation and delineating
miRNA-dependent effects as their effects are directly aimed at
speciﬁc miRNA targets.5.3.2. miRNA sponges
miRNA sponges (reviewed in [76]) are a cost-effective alterna-
tive to oligonucleotide inhibitors, which also allows for establish-
ing long term repression or tissue-speciﬁc repression in vivo. The
principle of a sponge is simple – it is a transcript carrying multiple
miRNA binding sites, which is highly expressed and sequesters
speciﬁc cellular miRNAs [76,77]. Sponges allow for inducing
selected miRNA suppression in vivo [78] and can achieve suppres-
sion of several selected miRNAs in a speciﬁc tissue – exempliﬁed
by repression of three miRNAs in the retina of a transgenic mouse
model [79].
6. Identiﬁcation and validation of miRNA targets
Target identiﬁcation & validation is a common problem in the
miRNA ﬁeld. Numerous experimental strategies can be used to
solve it [80,81]. Below, I will provide suggestions to avoid being
entangled in the complexity of the problem and discuss which
strategies are less likely to produce artifacts.
6.1. Target identiﬁcation
Several biochemical approaches were developed for direct iso-
lation and identiﬁcation of target mRNAs associated with miRISC
(reviewed in detail in [80,81]). A powerful methods is crosslinking
followed by AGO immunoprecipitation and NGS known as high
throughput sequencing of crosslinking immunoprecipitation
(HITS-CLIP) [82,83]. HITS-CLIP allows for narrowing down a
miRNA bound region and, when combined with selective miRNA
inhibition (see below), it offers a great tool to identify natural
miRNA targets regardless of their conservation. A further improve-
ment of the approach came with crosslinking using photoactivat-
able nucleosides such as 4-thiouridine, a CLIP modiﬁcation
known as photoactivatable-ribonucleoside-enhanced crosslinking
and immunoprecipitation (PAR-CLIP) [84]. PAR-CLIP offers more
efﬁcient crosslinking, hence up to three orders of magnitude better
RNA recovery than HITS-CLIP [84]. Importantly, PAR-CLIP also
allows for precise localization of miRNA binding site as
cross-linked 4-thiouridine marks the cross-linked site with fre-
quent thymidine to cytidine transition, which is revealed by NGS
[84].
While CLIP approaches provide outstanding tools for miRNA
target identiﬁcation, they are not always accessible to a common
user mainly because they require signiﬁcant expertise in
proteomics and bioinformatics, good antibodies, and sufﬁcient
funding. Therefore, common users usually opt for fallible bioinfor-
matic target prediction and become entangled in the ever-growinglist of prediction tools [85]. Discussing complexity of miRNA target
prediction is beyond the scope of this article, so I will only brieﬂy
touch upon this topic from the perspective of a common user.
Prediction algorithms incorporate in one way or another the pres-
ence of the ‘‘seed’’ region in the 30UTR and inter-species conserva-
tion [10,11]. The miRBase lists targets predicted for each miRNA by
six different sources and experimentally validated ones [25].
Target prediction distinguishes canonical (conserved), and
non-canonical targets. The ﬁrst category is easier to identify com-
putationally as the prediction can rely on the higher conservation
of the miRNA binding site (particularly the seed complementarity).
The second category comprises relatively recently acquired miRNA
targets that are not commonly suppressed in different species. I
suggest to start bioinformatics target prediction by surveying data
deposited in the miRBase and then combine it with analysis of
putative targets using TargetScan PCT [26] and MIRZA-G-C, which
performed well in a recent study [86].
6.2. Target validation
When miRNA transfection or expression is used for target vali-
dation, one has to be extremely cautious about data interpretation.
Consider the following (common) scenario: miRNA proﬁling of a
biological model system reveals a highly differentially expressed
miRNA. Target prediction leads to an interesting gene. Its 30UTR
is used in a luciferase reporter, which is co-transfected with the
miRNA and it is shown that the presence of the miRNA leads to
repression of the reporter, which is in turn results in the interested
gene to be proclaimed a validated miRNA target and the differen-
tially expressed miRNA is implicated in the studied process.
What could be wrong?
First, current proﬁling techniques are extremely sensitive and
can quantify truly minuscule expression levels, which may not
be physiologically relevant. Thus, when considering normal
miRNA-mediated target interaction, one has to consider how well
the physiological stoichiometry supports the proposed model. For
example, rice miRNAs were reported to reach femtomolar levels
in plasma of subjects consuming rice [87]. Regardless whether or
not miRNAs from food emerge intact in the bloodstream, such
amounts essentially rule out physiologically relevant target repres-
sion by normal miRNA function. 10 fM corresponds to approxi-
mately 6  109 mol/L while a volume of a somatic cell is within
picoliters. Thus, there would be (much) less than one miRNA mole-
cule per cell at 10 fM concentration. For comparison, concentra-
tions of siRNAs for inducing efﬁcient and speciﬁc RNAi are
typically within nanomolar range, some six orders of magnitude
higher (e.g. [88]).
Therefore, a good research practice requires insights into the
stoichiometry of miRNA and target abundancies. As a rule of a
thumb, most abundant miRNAs exert strongest effects on the tran-
scriptome, so a highly abundant cell-speciﬁc miRNA is the ﬁrst best
candidate for a physiologically important role while the probability
of a strong physiological effect of a miRNA, which constitutes <1%
of all cellular miRNAs is small. The argument that rare miRNA can
still efﬁciently repress rare targets is generally invalid because a
rare miRNA would bind to all accessible binding sites including
those on highly abundant mRNAs, which will effectively outcom-
pete binding sites in rare targets. Therefore, for differential
miRNA proﬁling, I highly recommend not to rely on ﬁltering based
just on a relative change. Instead, after obtaining fold-change and
P-value data for differentially expressed miRNAs, inspect the corre-
sponding MA plot or scatter plot indicating miRNA abundance and
focus ﬁrst on signiﬁcant changes of the 20–30 most abundant
miRNAs. Importantly, at the same time, one has to take into the
account also sample heterogeneity where highly abundant, func-
tionally signiﬁcant miRNAs might have an apparent low
1700 P. Svoboda / FEBS Letters 589 (2015) 1694–1701abundance in the studied miRNA population because cells express-
ing such miRNAs would constitute only a small fraction of the
sample.
Second, target validation by using a reporter targeted by
over-expressed miRNA is prone to two sources of artifacts yielding
false positive results: (i) Hundreds of genes, which are primary tar-
gets of an overexpressed miRNA [15,28], may affect expression of
many other genes (secondary targets) and one of the targets can
affect the reporter by a mechanism independent of direct miRNA
interaction with the reporter. Accordingly, one needs to use appro-
priate controls. It is not enough to monitor a reporter carrying a
tested 30UTR in the presence and absence of a miRNA. Adding
and unrelated small RNA does not provide a complete remedy
because if the ﬁrst miRNA is causing an artifact, which affects
the reporter, a second control miRNA most likely will not have
such an effect. This is an analogy to RNAi off-targeting in RNAi
experiments, where each siRNA has its own and speciﬁc
off-target set of repressed mRNAs [88]. Therefore, a better control
for target validation is using a second reporter, in which the pre-
dicted miRNA binding site(s) are mutated by point mutations.
Such reporter should have the same expression level as the one
with the wild-type 30UTR in the miRNA absence but it should not
be repressed in the presence of the miRNA. (ii) Delivering both,
the miRNA and the reporter can produce a positive, but
non-physiological outcome. In my opinion, a much more convinc-
ing result is obtained when one uses a cell expressing physiological
levels of the miRNA, titrates levels of the reporter to reveal the
range of effective repression by the endogenous miRNA and then
uses a miRNA-speciﬁc inhibitor and, if being truly meticulous, a
target protector.
7. Conclusions and perspectives
miRNAs are ubiquitous regulators implicated in almost every
studied biological process in animals. At the same time, not every
promising correlation reveals a direct miRNA-mediated repression,
not every miRNA has a function, and not every important repro-
gramming process must involve miRNAs [64,89]. Prudence should
accompany the search for biologically signiﬁcant miRNA-mediated
regulations. As a rule of a thumb, such regulation needs to be sup-
ported by co-expression and inverse correlation between miRNA
and its target levels, experimental validation of miRNA targeting,
and evidence that physiological miRNA-mediated effects are
responsible for observed biological effect.
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